Lv4
490 积分 2024-02-26 加入
PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancer
6天前
已完结
Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
8天前
已完结
Identification of triazolyl KAT6 inhibitors via a templated fragment approach
1个月前
已完结
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents
1个月前
已完结
The expanding role for small molecules in immuno-oncology
2个月前
已完结
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
3个月前
已完结
Efficacy and safety of taletrectinib for treatment of ROS1 positive non-small cell lung cancer: A systematic review
3个月前
已完结
High-resolution mass spectrometry-based approach for the identification and profiling of the metabolites of taletrectinib formed in liver microsomes
3个月前
已完结
Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1þ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 Studies
3个月前
已完结
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
3个月前
已完结
皖公网安备34019202002308
